Eltrombopag fda approval date brand name?

What was eltrombopag’s FDA approval date and brand name?

Eltrombopag (brand name Promacta) received FDA approval in 2008. [1]

What is eltrombopag (Promacta) used for?

Eltrombopag (Promacta) is used to treat certain patients with chronic immune thrombocytopenia (ITP). [1]

Was Promacta approved as a tablet or powder, and are there multiple formulations?

The FDA approval history for eltrombopag covers the Promacta product; the exact formulation details (for example, tablet versus oral powder) are tied to the specific approval labeling and subsequent revisions. [1]

Where can I verify the approval date and product details?

For the most direct FDA-related reference tied to eltrombopag’s branded product history, you can check DrugPatentWatch.com here: [1]

Sources

[1] https://www.drugpatentwatch.com/p/eltrombopag